FSGAX
Price
$40.50
Change
+$0.65 (+1.63%)
Updated
Apr 11 closing price
Net Assets
3.31B
PMAQX
Price
$42.63
Change
+$0.74 (+1.77%)
Updated
Apr 11 closing price
Net Assets
27.72B
Ad is loading...

FSGAX vs PMAQX

Header iconFSGAX vs PMAQX Comparison
Open Charts FSGAX vs PMAQXBanner chart's image
Franklin Small-Mid Cap Growth Adv
Price$40.50
Change+$0.65 (+1.63%)
VolumeN/A
Net Assets3.31B
Principal MidCap R6
Price$42.63
Change+$0.74 (+1.77%)
VolumeN/A
Net Assets27.72B
FSGAX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSGAX vs. PMAQX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSGAX is a Buy and PMAQX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 27.7B vs. FSGAX (3.31B). PMAQX pays higher dividends than FSGAX: PMAQX (0.20) vs FSGAX (0.01). FSGAX was incepted earlier than PMAQX: FSGAX (28 years) vs PMAQX (8 years). FSGAX (0.63) and PMAQX (0.60) have similar cost to investors . FSGAX is a more actively managed with annual turnover of: 37.02 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than FSGAX: PMAQX (0) vs FSGAX (100000). PMAQX annual gain was more profitable for investors over the last year : 1.93 vs. FSGAX (-8.66). PMAQX return over 5 years is better than : 63.19 vs. FSGAX (20.26).
FSGAXPMAQXFSGAX / PMAQX
Total Expense Ratio0.610.60102%
Annual Report Gross Expense Ratio0.630.60105%
Fund Existence28 years8 years-
Gain YTD-14.283-6.139233%
Front LoadN/AN/A-
Min. Initial Investment1000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.31B27.7B12%
Annual Yield % from dividends0.010.204%
Returns for 1 year-8.661.93-449%
Returns for 3 years-4.7517.25-28%
Returns for 5 years20.2663.1932%
Returns for 10 years-5.04N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LADTX23.36N/A
N/A
Lord Abbett Developing Growth R5
WRLDX34.35N/A
N/A
Scharf Global Opportunity Institutional
CCPCX13.23N/A
N/A
FS Chiron Capital Allocation C
MXETX10.83N/A
N/A
Empower Core Strategies US Eq Inv
DRGVX41.78N/A
N/A
BNY Mellon Dynamic Value Fund I